1. Review current treatment guidelines for advanced urothelial carcinoma

2. Discuss clinical evidence of immunotherapy for advanced urothelial carcinoma


1.     Gained a deeper knowledge of the evolution of tumor boards

2.     Better understand the diversity of perceived purposes of tumor boards

3.     Improve their grasp of data supporting the use of tumor boards


Session date: 
01/28/2019 - 12:00pm to 1:00pm CST
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Carolina Soto Chervin, MD, PhD and Garth W. Strohbehn, MD, Phil